Sterling Capital Management’s GeneDx Holdings WGS Stock Holding History

Sterling Capital Management’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.81K	Sell	70 -53	-43%	-$3.01K	﹤0.01%	2644
2026 Q1	$7.9K	Sell	123 -2	-2%	-$182	﹤0.01%	2500
2025 Q4	$16.3K	Buy	125 +79	+172%	+$10.8K	﹤0.01%	2343
2025 Q3	$4.96K	Buy	46 +1	+2%	+$109	﹤0.01%	2764
2025 Q2	$4.15K	Sell	45 -149	-77%	-$11.7K	﹤0.01%	2612
2025 Q1	$17.2K	Sell	194 -158	-45%	-$13.7K	﹤0.01%	1698
2024 Q4	$27.1K	Buy	352 +316	+878%	+$22.1K	﹤0.01%	1786
2024 Q3	$1.53K	Buy	+36	New	+$1.22K	﹤0.01%	2323

Other funds holding WGS

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Sterling Capital Management's WGS Position: Q2 2026 in Review

Sterling Capital Management reduced its GeneDx Holdings (WGS) stake by 43% in Q2 2026, selling an estimated $3.01K and leaving 70 shares worth $4.81K. The position accounts for ﹤0.01% of the portfolio, ranked #2644.

Sterling Capital Management first reported a position in WGS in Q3 2024 and has held it in 8 quarters since. The position peaked at $27.1K in Q4 2024. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

Sterling Capital Management held 70 shares of GeneDx Holdings worth $4.81K as of Q2 2026.
Sterling Capital Management sold 53 GeneDx Holdings shares in Q2 2026, an estimated $3.01K.
GeneDx Holdings made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2644 holding.
Sterling Capital Management first reported a position in GeneDx Holdings in Q3 2024 and has held it in 8 quarters since.
Sterling Capital Management's GeneDx Holdings position peaked at $27.1K in Q4 2024.
223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.